Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-01-02 @ 8:22 AM
Study NCT ID:
NCT00678535
Status:
COMPLETED
Last Update Posted:
2014-07-21
First Post:
2008-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2012-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-13
First Submit QC Date:
None
Study First Post Date:
2008-05-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-03-30
Results First Submit QC Date:
None
Results First Post Date:
2013-05-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-11
Last Update Post Date:
2014-07-21
Last Update Post Date Type:
ESTIMATED